Found: 96
Select item for more details and to access through your institution.
First‐in‐human, phase I/IIa study of CRLX301, a nanoparticle drug conjugate containing docetaxel, in patients with advanced or metastatic solid malignancies.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 4, p. 1047, doi. 10.1007/s10637-021-01081-x
- By:
- Publication type:
- Article
A Phase II study of bosentan, a dual endothelin receptor antagonist, as monotherapy in patients with stage IV metastatic melanoma.
- Published in:
- Investigational New Drugs, 2007, v. 25, n. 3, p. 247, doi. 10.1007/s10637-006-9014-7
- By:
- Publication type:
- Article
A melanoma-associated germline mutation in exon 1β inactivates p14ARF.
- Published in:
- Oncogene, 2001, v. 20, n. 39, p. 5543, doi. 10.1038/sj.onc.1204728
- By:
- Publication type:
- Article
The melanoma-associated 24 base pair duplication in p16INK4a is functionally impaired.
- Published in:
- International Journal of Cancer, 2005, v. 117, n. 4, p. 569, doi. 10.1002/ijc.21265
- By:
- Publication type:
- Article
Filgrastim in patients with chemotherapy-induced febrile neutropenia. A double-blind, placebo-controlled trial.
- Published in:
- 1994
- By:
- Publication type:
- journal article
Increased MAPK reactivation in early resistance to dabrafenib/trametinib combination therapy of BRAF-mutant metastatic melanoma.
- Published in:
- Nature Communications, 2014, v. 5, n. 12, p. 5694, doi. 10.1038/ncomms6694
- By:
- Publication type:
- Article
Deletion mapping suggests that the 1p22 melanoma susceptibility gene is a tumor suppressor localized to a 9‐mb interval.
- Published in:
- Genes, Chromosomes & Cancer, 2004, v. 41, n. 1, p. 56, doi. 10.1002/gcc.20056
- By:
- Publication type:
- Article
CDKN2A (P16<sup>INK4a</sup>) and CDK4 mutation analysis in 131 Australian melanoma probands: Effect of family history and multiple primary melanomas.
- Published in:
- Genes, Chromosomes & Cancer, 1999, v. 25, n. 4, p. 339, doi. 10.1002/(SICI)1098-2264(199908)25:4<339::AID-GCC5>3.0.CO;2-H
- By:
- Publication type:
- Article
Neoadjuvant systemic therapy for breast cancer: the Westmead experience.
- Published in:
- ANZ Journal of Surgery, 2018, v. 88, n. 6, p. 640, doi. 10.1111/ans.14158
- By:
- Publication type:
- Article
Hypermethylation of Circulating Free DNA in Cutaneous Melanoma.
- Published in:
- Applied Sciences (2076-3417), 2019, v. 9, n. 23, p. 5074, doi. 10.3390/app9235074
- By:
- Publication type:
- Article
Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The Use of L-dopa and Carbidopa in Metastatic Malignant Melanoma.
- Published in:
- Journal of Investigative Dermatology, 1991, v. 96, n. 1, p. 85, doi. 10.1111/1523-1747.ep12515896
- By:
- Publication type:
- Article
Differential activity of MEK and ERK inhibitors in BRAF inhibitor resistant melanoma.
- Published in:
- Molecular Oncology, 2014, v. 8, n. 3, p. 544, doi. 10.1016/j.molonc.2014.01.003
- By:
- Publication type:
- Article
Clinicians' attitudes and perceived barriers and facilitators to cancer treatment clinical practice guideline adherence: a systematic review of qualitative and quantitative literature.
- Published in:
- 2020
- By:
- Publication type:
- journal article
bcGST—an interactive bias-correction method to identify over-represented gene-sets in boutique arrays.
- Published in:
- Bioinformatics, 2019, v. 35, n. 8, p. 1350, doi. 10.1093/bioinformatics/bty783
- By:
- Publication type:
- Article
Pneumocystis jirovecii in a patient on dose-dense chemotherapy for early breast cancer.
- Published in:
- Respirology Case Reports, 2019, v. 7, n. 7, p. 1, doi. 10.1002/rcr2.459
- By:
- Publication type:
- Article
Targeted BRAF Inhibition Impacts Survival in Melanoma Patients with High Levels of Wnt/β-Catenin Signaling.
- Published in:
- PLoS ONE, 2014, v. 9, n. 4, p. 1, doi. 10.1371/journal.pone.0094748
- By:
- Publication type:
- Article
Inter- and Intra-Patient Heterogeneity of Response and Progression to Targeted Therapy in Metastatic Melanoma.
- Published in:
- PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0085004
- By:
- Publication type:
- Article
Prediction of life-expectancy in hospice patients: identification of novel prognostic factors.
- Published in:
- Palliative Medicine, 1993, v. 7, n. 3, p. 199, doi. 10.1177/026921639300700306
- By:
- Publication type:
- Article
Future perspectives in melanoma research: meeting report from the ''Melanoma Bridge'', Napoli, December 5th-8th 2013.
- Published in:
- 2014
- By:
- Publication type:
- Proceeding
Impact of baseline and nadir neutrophil index in non-small cell lung cancer and ovarian cancer patients: Assessment of chemotherapy for resolution of unfavourable neutrophilia.
- Published in:
- Journal of Translational Medicine, 2013, v. 11, n. 1, p. 1, doi. 10.1186/1479-5876-11-189
- By:
- Publication type:
- Article
Impact of baseline and nadir neutrophil index in non-small cell lung cancer and ovarian cancer patients: Assessment of chemotherapy for resolution of unfavourable neutrophilia.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Drug treatment for melanoma: progress, but who pays? Comment.
- Published in:
- 2012
- By:
- Publication type:
- letter
Letters.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Drug treatment for melanoma: progress, but who pays?
- Published in:
- 2012
- By:
- Publication type:
- Editorial
Medical heat for climate change.
- Published in:
- Medical Journal of Australia, 2006, v. 184, n. 11, p. 582, doi. 10.5694/j.1326-5377.2006.tb00385.x
- By:
- Publication type:
- Article
Hypertrophic osteoarthropathy from pulmonary metastatic phyllodes tumour of the breast.
- Published in:
- Medical Journal of Australia, 2004, v. 181, n. 5, p. 279, doi. 10.5694/j.1326-5377.2004.tb06272.x
- By:
- Publication type:
- Article
Identification of a melanoma susceptibility locus and somatic mutation in TET2.
- Published in:
- Carcinogenesis, 2014, v. 35, n. 9, p. 2097
- By:
- Publication type:
- Article
Mitogen‐activated protein kinase dependency in BRAF/RAS wild‐type melanoma: A rationale for combination inhibitors.
- Published in:
- Pigment Cell & Melanoma Research, 2020, v. 33, n. 2, p. 345, doi. 10.1111/pcmr.12824
- By:
- Publication type:
- Article
Oncogenic signaling in uveal melanoma.
- Published in:
- Pigment Cell & Melanoma Research, 2018, v. 31, n. 6, p. 661, doi. 10.1111/pcmr.12708
- By:
- Publication type:
- Article
Metastasis‐specific patterns of response and progression with anti‐PD‐1 treatment in metastatic melanoma.
- Published in:
- Pigment Cell & Melanoma Research, 2018, v. 31, n. 3, p. 404, doi. 10.1111/pcmr.12675
- By:
- Publication type:
- Article
Pharmacokinetics of dabrafenib in a patient with metastatic melanoma undergoing haemodialysis.
- Published in:
- Pigment Cell & Melanoma Research, 2017, v. 30, n. 1, p. 68, doi. 10.1111/pcmr.12557
- By:
- Publication type:
- Article
Residual FDG- PET metabolic activity in metastatic melanoma patients with prolonged response to anti- PD-1 therapy.
- Published in:
- Pigment Cell & Melanoma Research, 2016, v. 29, n. 5, p. 572, doi. 10.1111/pcmr.12503
- By:
- Publication type:
- Article
PD-L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti- PD-1/ PD- L1 clinical trials.
- Published in:
- Pigment Cell & Melanoma Research, 2015, v. 28, n. 3, p. 245, doi. 10.1111/pcmr.12340
- By:
- Publication type:
- Article
Paradoxical oncogenesis: are all BRAF inhibitors equal?
- Published in:
- Pigment Cell & Melanoma Research, 2013, v. 26, n. 5, p. 611, doi. 10.1111/pcmr.12132
- By:
- Publication type:
- Article
Secondary c-Kit mutations confer acquired resistance to RTK inhibitors in c-Kit mutant melanoma cells.
- Published in:
- Pigment Cell & Melanoma Research, 2013, v. 26, n. 4, p. 518, doi. 10.1111/pcmr.12107
- By:
- Publication type:
- Article
Effects of BRAF inhibitors on human melanoma tissue before treatment, early during treatment, and on progression.
- Published in:
- Pigment Cell & Melanoma Research, 2013, v. 26, n. 4, p. 499, doi. 10.1111/pcmr.12098
- By:
- Publication type:
- Article
p16 <sup>INK</sup><sup>4a</sup> deficiency promotes DNA hyper-replication and genetic instability in melanocytes.
- Published in:
- Pigment Cell & Melanoma Research, 2013, v. 26, n. 2, p. 236, doi. 10.1111/pcmr.12062
- By:
- Publication type:
- Article
Wild type and melanoma-associated mutant p16<sup>INK4a</sup> proteins do not oligomerize in vivo.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Clinicopathologic features associated with efficacy and long-term survival in metastatic melanoma patients treated with BRAF or combined BRAF and MEK inhibitors.
- Published in:
- 2015
- By:
- Publication type:
- journal article
The nature and management of metastatic melanoma after progression on BRAF inhibitors: Effects of extended BRAF inhibition.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 20, p. 3142, doi. 10.1002/cncr.28851
- By:
- Publication type:
- Article
Outcomes of patients with metastatic melanoma treated with immunotherapy prior to or after BRAF inhibitors.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 11, p. 1695, doi. 10.1002/cncr.28620
- By:
- Publication type:
- Article
Patterns of response and progression in patients with BRAF-mutant melanoma metastatic to the brain who were treated with dabrafenib.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 4, p. 530, doi. 10.1002/cncr.28445
- By:
- Publication type:
- Article
Number of primary melanomas is an independent predictor of survival in patients with metastatic melanoma.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 18, p. 4519, doi. 10.1002/cncr.27693
- By:
- Publication type:
- Article
A Phase 2, Randomized Study of SB-485232, rhIL48, in Patients With Previously Untreated Metastatic Melanoma.
- Published in:
- Cancer (0008543X), 2009, v. 115, n. 4, p. 859, doi. 10.1002/cncr.24100
- By:
- Publication type:
- Article
Optimizing combination dabrafenib and trametinib therapy in BRAF mutation-positive advanced melanoma patients: Guidelines from Australian melanoma medical oncologists.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2016, v. 12, p. 5, doi. 10.1111/ajco.12656
- By:
- Publication type:
- Article
Australian doctors and nuclear war.
- Published in:
- Medical Journal of Australia, 1982, v. 2, n. 3, p. 109, doi. 10.5694/j.1326-5377.1982.tb124262.x
- By:
- Publication type:
- Article
IMMUNOBLASTIC LYMPHOMA IN HUSBAND AND WIFE.
- Published in:
- Medical Journal of Australia, 1980, v. 1, n. 4, p. 173, doi. 10.5694/j.1326-5377.1980.tb134740.x
- By:
- Publication type:
- Article
Musculoskeletal immune‐related adverse events with the use of checkpoint inhibitors in malignancy.
- Published in:
- Internal Medicine Journal, 2022, v. 52, n. 5, p. 818, doi. 10.1111/imj.15123
- By:
- Publication type:
- Article
Survey of practices around pharmaceutical company funding for continuing professional development among medical oncologists and trainees in Australia.
- Published in:
- Internal Medicine Journal, 2017, v. 47, n. 8, p. 888, doi. 10.1111/imj.13482
- By:
- Publication type:
- Article